• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Use of diuretics in the treatment of ascites in patients with cirrhosis].

作者信息

Bourgeois N, Devaere S, Adler M, Cremer M

机构信息

Service Médico-Chirurgical de Gastro-entérologie, Hôpital Erasme, Université Libre de Bruxelles.

出版信息

Acta Gastroenterol Belg. 1990 Mar-Apr;53(2):256-60.

PMID:2267905
Abstract

The cirrhotic patient with ascites has an increased tubular reabsorption of sodium. Diuretic therapy allows an urinary loss of sodium. The strongest diuretics which inhibit sodium reabsorption in the ascending limb of the loop of Henle (like furosemide) are not the most effective in cirrhotic patients; indeed the increased load of sodium arriving in the distal part of the tubule is reabsorbed because of hyperaldosteronism. Potassium-sparing diuretics, like spironolactone, which act beyond the sites of reabsorption of most of the filtered sodium, are mostly effective when combined with other diuretics which impair sodium reabsorption more proximally. We propose to treat ascites by: 1. Sodium restriction (maximum: 60 mmol per day); 2. Spironolactone 100 to 500 mg per day, combined with furosemide 40 to 200 mg per day if spironolactone does not induce a natriuretic effect.

摘要

相似文献

1
[Use of diuretics in the treatment of ascites in patients with cirrhosis].
Acta Gastroenterol Belg. 1990 Mar-Apr;53(2):256-60.
2
Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.肝硬化腹水:利尿剂抵抗的发病机制及托拉塞米的长期疗效与安全性
Cardiology. 1994;84 Suppl 2:87-98. doi: 10.1159/000176461.
3
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.非氮质血症肝硬化患者腹水利尿治疗阶梯式护理方法中对螺内酯无反应的病理生理学解释。
Hepatology. 1991 Aug;14(2):231-6.
4
[Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites].[非限钠饮食联合利尿剂对肝硬化腹水患者血浆肾素、肾血流量的影响]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Feb;27(1):50-3.
5
An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.肝硬化腹水的最佳利尿方案。一项评估螺内酯和呋塞米安全性及疗效的对照试验。
JAMA. 1977 Mar 7;237(10):972-5.
6
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.螺内酯单用或与呋塞米联用治疗非氮质血症性肝硬化中度腹水:一项疗效与安全性的随机对照研究
J Hepatol. 2003 Aug;39(2):187-92. doi: 10.1016/s0168-8278(03)00188-0.
7
Pathogenesis of ascites and renal salt retention in cirrhosis.
J Investig Med. 1999 May;47(5):183-202.
8
Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.通过预处理分数钠排泄预测肝硬化腹水的利尿剂动员
Klin Wochenschr. 1990 Jun 5;68(11):545-51. doi: 10.1007/BF01667146.
9
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.速尿与螺内酯治疗非氮质血症性肝硬化腹水疗效的随机对照研究。利尿反应与肾素-醛固酮系统活性之间的关系。
Gastroenterology. 1983 May;84(5 Pt 1):961-8.
10
Loop diuretic therapy in liver cirrhosis with ascites.肝硬化腹水的袢利尿剂治疗
J Cardiovasc Pharmacol. 1993;22 Suppl 3:S51-8. doi: 10.1097/00005344-199322003-00007.